Fundz

Fundz Deep Dive

Everything you need to win Marie Evangelista — in one platform.

Who to reach, what to say, and why now on Marie Evangelista — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Marie Evangelista — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Circle Pharma Announces Appointment of Marie Evangelista As Senior Vice President and Head of Cancer Biology, and Constantine Kreatsoulas As Senior Vice President and Head of Discovery Technology Sciences

PRIVATESep 16, 2024•almost 2 years ago

Position

Head of Cancer Biology

Company

Circle Pharma

Marie Evangelista
San FranciscoHealthcareHealth Care

Description

Circle Pharma, Inc has announced the appointment of Marie Evangelista as Senior Vice President and Head of Cancer Biology, and Constantine Kreatsoulas as Senior Vice President and Head of Discovery Technology Sciences. These appointments align with the company’s investments in its pipeline of macrocycle therapies, including its lead program, CID-078, currently being evaluated in a Phase 1 clinical trial in solid tumors.

Company Information

Company

Circle Pharma

Location

681 GATEWAY BLVD

San Francisco, California, United States

About

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Circle Pharma's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.